Amelioration of the neurological phenotype in PKU mouse model emphasizes the potential of base editing for metabolic diseases

Timo Keskinen, Mervi E. Hyvönen

Open source

DOI
10.1016/j.omta.2026.201828
Published
2026-09
Container
Molecular Therapy Advances
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omta.2026.201828,
  title = {Amelioration of the neurological phenotype in PKU mouse model emphasizes the potential of base editing for metabolic diseases},
  author = {Timo Keskinen and Mervi E. Hyvönen},
  year = {2026},
  journal = {Molecular Therapy Advances},
  doi = {10.1016/j.omta.2026.201828},
  url = {https://doi.org/10.1016/j.omta.2026.201828}
}

RIS

TY  - JOUR
TI  - Amelioration of the neurological phenotype in PKU mouse model emphasizes the potential of base editing for metabolic diseases
AU  - Timo Keskinen
AU  - Mervi E. Hyvönen
PY  - 2026
JO  - Molecular Therapy Advances
DO  - 10.1016/j.omta.2026.201828
UR  - https://doi.org/10.1016/j.omta.2026.201828
ER  - 

APA

Keskinen, T., & Hyvönen, M. E. (2026). Amelioration of the neurological phenotype in PKU mouse model emphasizes the potential of base editing for metabolic diseases. Molecular Therapy Advances. https://doi.org/10.1016/j.omta.2026.201828

Source records